Valvular Heart Disease and the Use of Dopamine Agonists for Parkinsons Disease
NEJM 356:39-46, Zanettini,R.,et al, 2007
Dopamine Agonists and the Risk of Cardiac Valve Regurgitation
NEJM 356:29-38, Schade,R.,et al, 2007
Epidemiology and Clinical Outcomes of Infective Endocarditis in Hemodialysis Patients
Ann Thorac Surg 83:2081-2086, 2086, Kamalakannan,D.,et al, 2007
Dopamine Agonists and Cardiac Valvulopathy in Parkinson Disease: A Case-Control Study
Neurol 67:1225-1229, Yamamoto,M.,et al, 2006
Treatment of Parkinson's Disease with Pergolide and Relation to Restrictive Valvular Heart Disease
Lancet 363:1179-1183, Van Camp,G.,et al, 2004
Heart Valvular Disease in Patients with Parkinson's Disease Treated with High-Dose Pergolide
Neurol 61:859-861, VanCamp,G.,et al, 2003
Valvular Heart Disease Associated with Fenfluramine-Phentermine
NEJM 337:581-588, 629, 635, 63697., Connolly,H.M.,et al, 1997
Transesophageal Echocardiography
NEJM 332:1268-1279, Daniel,W.G.&Mugge,A., 1995
Endocarditis in Intravenous Drug Abusers
Emerg Med Clin N Am 8:665-681, Roberts,R.&Slovis,C.M., 1990